The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters
The grants are expected to be received over the next three years, commencing March 2022
The companies plan to use the proceeds to retire debt and expand operations
This decision does not impact the ongoing AReSVi 006 phase III trial for RSV older adults.
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
Recall does not include any metabolic deficiency nutrition formulas
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Nirsevimab is the first investigational long-acting antibody designed to protect all infants for the respiratory syncytial virus season with a single dose
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
Subscribe To Our Newsletter & Stay Updated
